The global metabolomics market, valued at USD 2.7 billion in 2023, is projected to grow significantly, with a compound annual growth rate (CAGR) of 12.3% from 2024 to 2034. By 2034, it is expected to exceed USD 9.5 billion. This growth is driven by several factors, including the increasing demand for personalized medicine, the rise in chronic disease prevalence, and the growing application of...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian